SpringWorks Therapeutics, Inc. (SWTX)

SpringWorks Therapeutics Revenue

In the year 2024, SpringWorks Therapeutics had annual revenue of $191.59M with 3,417.33% growth. SpringWorks Therapeutics had revenue of $61.55M in the quarter ending December 31, 2024, with 1,029.96% growth.

• Revenue (ttm): $191.59M
• Revenue Growth: +3,417.33%
• P/S Ratio: 17.82
• Revenue / Employee: $520,622
• Employees: 368
• Market Cap: 3.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	191.59M	186.14M	3,417.33%
Dec 31, 2023	5.45M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	35.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.